Melatonin levels decrease in type 2 diabetic patients with cardiac autonomic neuropathy.
about
Daily rhythms of plasma melatonin, but not plasma leptin or leptin mRNA, vary between lean, obese and type 2 diabetic menDiabetic neuropathy: mechanisms to managementAntioxidant effect of melatonin on the functional activity of colostral phagocytes in diabetic women.Alteration of melatonin secretion in patients with type 2 diabetes and proliferative diabetic retinopathy.Melatonin as a naturally occurring co-substrate of quinone reductase-2, the putative MT3 melatonin membrane receptor: hypothesis and significance.Melatonin, endocrine pancreas and diabetes.The effect of melatonin on endothelial dysfunction in patient undergoing coronary artery bypass grafting surgeryMelatonin, mitochondria, and the metabolic syndrome.Chronomedicine and type 2 diabetes: shining some light on melatonin.Increased melatonin levels in aqueous humor of patients with proliferative retinopathy in type 2 diabetes mellitus.Diabetic Goto Kakizaki rats as well as type 2 diabetic patients show a decreased diurnal serum melatonin level and an increased pancreatic melatonin-receptor status.Melatonin synthesis impairment as a new deleterious outcome of diabetes-derived hyperglycemia.Melatonin attenuates smoking-induced hyperglycemia via preserving insulin secretion and hepatic glycogen synthesis in rats.The insulin-melatonin antagonism: studies in the LEW.1AR1-iddm rat (an animal model of human type 1 diabetes mellitus).Low testosterone levels and unimpaired melatonin secretion in young males with metabolic syndrome.Hepatoprotective effects of melatonin against pronecrotic cellular events in streptozotocin-induced diabetic rats.Low serum melatonin levels are associated with erectile dysfunction
P2860
Q28729861-BF347263-EF8E-4B90-B2E4-42550D53B1B9Q33554384-897C2640-5E1B-4F30-8DBC-50F13746D5D0Q34599706-195A8F74-6CDC-448B-917E-58B3185213E0Q35015863-D41009D3-BFB8-497E-9D5F-C67CBC97BA9AQ36957964-A30657E0-6D62-4318-9522-7E7DF91C1CB7Q37031601-D28D8191-F5A7-4626-A612-5D638895C770Q37504626-FDC74AE3-19A5-4D14-9D58-1BB4C0BC1636Q38618827-6A1BFDAF-4025-47D6-AAFB-49B968B31080Q39040818-E1A69B60-F745-4161-B48A-35CDEA08E7C2Q42749922-86EEDD95-8C76-49F4-93D9-6101D55A6E54Q46915158-9F0396E8-5CEE-44D3-89AF-F1EF6D321C82Q48107357-DC64C432-BEA8-42AF-907C-2A6738F3103DQ50044791-6DC349D5-D576-4282-9F37-D08BAA620ED3Q51476122-9C208DD1-3097-496A-978A-A36E2F9E3E54Q51486383-7E3BDFF3-EC02-4CA5-BCF4-75C79600C2BEQ53063562-8E848610-8293-40D8-A680-2AE217093C61Q57178247-0AD7B9AA-AAEB-486A-8BBA-3DBAF12E7158
P2860
Melatonin levels decrease in type 2 diabetic patients with cardiac autonomic neuropathy.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Melatonin levels decrease in type 2 diabetic patients with cardiac autonomic neuropathy.
@en
Melatonin levels decrease in type 2 diabetic patients with cardiac autonomic neuropathy.
@nl
type
label
Melatonin levels decrease in type 2 diabetic patients with cardiac autonomic neuropathy.
@en
Melatonin levels decrease in type 2 diabetic patients with cardiac autonomic neuropathy.
@nl
prefLabel
Melatonin levels decrease in type 2 diabetic patients with cardiac autonomic neuropathy.
@en
Melatonin levels decrease in type 2 diabetic patients with cardiac autonomic neuropathy.
@nl
P2093
P2860
P1476
Melatonin levels decrease in type 2 diabetic patients with cardiac autonomic neuropathy.
@en
P2093
Ahmet Deger
Aylin Yildirir
Belkis Erbas
Giray Kabakci
Mustafa K Batur
Neslihan B Tutuncu
Serdar Aksoyek
Tanju Tutuncu
Tomris Erbas
Zehra Koray
P2860
P356
10.1111/J.1600-079X.2005.00213.X
P577
2005-08-01T00:00:00Z